IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies | URGN Stock NewsStockTitan·1 day ago, 10:05 PMURGN-6.94%
Urogen Pharma (NASDAQ:URGN) Reaches New 1-Year High - Here's What HappenedMarket Beat·1 day ago, 10:00 AMURGN-6.94%BLK-1.65%
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - Time to Buy?Market Beat·Aug 12 at 12:00 PMURGN-6.94%
UroGen Pharma (URGN) Is Up 21.7% After Q2 Revenue Triples And Loss Narrows Has The Bull Case Changed?Simplywall·Aug 10 at 06:33 PMURGN-6.94%
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - What's Next?Market Beat·Aug 6 at 05:00 AMURGN-6.94%
Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New Highrttnews·Aug 5 at 10:40 PMPRGO-1.86%BJDX-2.17%
Urogen Pharma (NASDAQ:URGN) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPSMarket Beat·Aug 5 at 01:56 PMURGN-6.94%
